ERBB2 and breast carcinoma: Zambrano and co-workers [26] have recently shown that SSP suppresses cell viability of Her2/neu-positive breast cancer cells (human JMT-1 cells, SMF (MMTV-neu) murine-derived mammary tumour cells) in the lower nM range.